Andere Kunden interessierten sich auch für
![Correlation of Caveolin-1 with VEGF in Osteosarcoma]( "Correlation of Caveolin-1 with VEGF in Osteosarcoma")
Correlation of Caveolin-1 with VEGF in Osteosarcoma29,99 €![Gene Expression in Epilepsy]( "Gene Expression in Epilepsy")
Gene Expression in Epilepsy24,99 €![Transient effects of ABR on DPOAES in normal hearing adults]( "Transient effects of ABR on DPOAES in normal hearing adults")
Transient effects of ABR on DPOAES in normal hearing adults26,99 €![FDA Clinical Outcome Assessments and CDISC QRS supplements]( "FDA Clinical Outcome Assessments and CDISC QRS supplements")
FDA Clinical Outcome Assessments and CDISC QRS supplements29,99 €![Discrepancy between clinical and final diagnosis of hysterectomy]( "Discrepancy between clinical and final diagnosis of hysterectomy")
Discrepancy between clinical and final diagnosis of hysterectomy35,99 €![Comparative Study of Amlaki Rasayana and Shankhaprakshalana on Amlaka]( "Comparative Study of Amlaki Rasayana and Shankhaprakshalana on Amlaka")
Comparative Study of Amlaki Rasayana and Shankhaprakshalana on Amlaka40,99 €![HIV/AIDS Treatments, Fight for a Cure]( "HIV/AIDS Treatments, Fight for a Cure")
HIV/AIDS Treatments, Fight for a Cure24,99 €
P53 is guardian of genome but interpretations are always context dependent.This study contains detailed investigations on the role of tumor suppressor p53 in the growth of breast cancer cells and chemotherapy induced apoptosis in these cells both in vitro and in vivo. In addition, it not only includes the strategies to enhance therapeutic potential of specific anticancer drugs in breast cancer chemotherapy but also describes the potential implications of chemotherapeutic drugs induced bystander cell killing.